The best lessons are taught at the School of Experience

Vice president, Patient Access, Novo Nordisk Canada, 2016-

Executive team member responsible for 20+ FTE across pricing, health economics and outcomes research, market access and public affairs

Director, Sales & Marketing Excellence, Novo Nordisk, 2013-2016

Executive office to EVP, Global Marketing and Medical Affairs responsible for innovation projects, Global Sales Forum and commercial capability building

Executive Assistant to Chief Operating Officer, Novo Nordisk, 2010-2015

Responsible for Product Management Committee activities including device R&D projects, product life cycle management, patent strategy and tactical local production

Market Access and Commercial Excellence Management, Novo Nordisk, 2010-2013

Responsible for staff function to CVP of Global Market Access & Commercial Excellence Britt Meelby Jensen (later CEO, DAKO and CEO Zealand Pharma)

Sr. Project Manager, Assignment in Strategic Development, Novo Nordisk, 2010

Responsible for establishment of global trial allocation function as part of a major reorganisation to simplify and align the Clinical, Medical and Regulatory Organisation

Sr. Project Manager, Insights and Forecasting, Novo Nordisk, 2007-2010

Responsible for strategic planning process, forecasting and insight generation e.g. customer behaviour and treatment dynamics

Credit Risk Analyst, Nykredit, 2005-2007

Responsible for statistical modelling and estimation of economic buffer required to withstand financial crisis. Part of successful implementation of IFRS and Basal II advance requirements

Close Menu